STILNOX

This brand name is authorized in Brazil, Cyprus, Estonia, France, Germany, Hong Kong SAR China, Israel, Lithuania, Malta, Mexico, Poland, Romania, Singapore, South Africa, Spain, Tunisia.

Active ingredients

The drug STILNOX contains one active pharmaceutical ingredient (API):

1	Zolpidem hemitartrate UNII WY6W63843K - ZOLPIDEM TARTRATE
	Zolpidem is an imidazopyridine which preferentially binds the omega-1 receptor subtype (also known as the benzodiazepine-1 subtype) which corresponds to GABA-A receptors containing the alpha-1 sub-unit, whereas benzodiazepines non-selectively bind both omega-1 and omega-2 subtypes. The modulation of the chloride anion channel via this receptor leads to the specific sedative effects demonstrated by zolpidem. These effects are reversed by the benzodiazepine antagonist flumazenil.
	Read more about Zolpidem

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STILNOX Film-coated tablet	MPI, EU: SmPC	Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CF02	Zolpidem	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CF Benzodiazepine related drugs
Discover more medicines within N05CF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	576720070081017, 576720070081117, 576720070081217, 576720070081317, 576720070081417, 576720070081517, 576721070095603, 576721070095703, 576721070095803
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00198344, 00723394, 00723595, 07243993, 07244001, 07478319, 07709724, 07711218, 15235186, 17866169, 17928479, 17938319
EE	Ravimiamet	1043211, 1068106, 1822317
ES	Centro de información online de medicamentos de la AEMPS	58470
FR	Base de données publique des médicaments	63179285
HK	Department of Health Drug Office	36433, 56391, 56392
IL	מִשְׂרַד הַבְּרִיאוּת	3374, 9349
LT	Valstybinė vaistų kontrolės tarnyba	1009438, 1009439, 1078646, 1080561, 1081953, 1090060, 1091093
MT	Medicines Authority	MA1359/03401, PI242/01401A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	044M98, 152M2008
PL	Rejestru Produktów Leczniczych	100063983, 100216702, 100271664, 100348378, 100354812, 100365649, 100462391
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62440001, W62440002, W62440003, W62440004
SG	Health Sciences Authority	07418P, 13402P, 13403P
TN	Direction de la Pharmacie et du Médicament	6463052
ZA	Health Products Regulatory Authority	29/2.2/0651